The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study
Latest Information Update: 17 Aug 2023
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Cystinuria
- Focus Proof of concept; Therapeutic Use
- 10 Aug 2023 Planned End Date changed from 1 Jun 2025 to 1 Jun 2026.
- 10 Aug 2023 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2025.
- 10 Aug 2023 Planned initiation date changed from 2 May 2023 to 2 May 2025.